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Resumo 
 
A metanfetamina (MET) é uma droga psicoestimulante altamente viciante cujo consumo na 
Europa tem vindo a aumentar nos últimos anos. Vários estudos têm demonstrado que o stress 
oxidativo, a excitotoxicidade, inflamação e a disfunção mitocondrial são alguns dos efeitos 
neurotóxicos da MET. Recentemente foi demonstrado que a MET compromete a função da 
barreira hemato-encefálica (BHE) e causa edema cerebral. A BHE é uma estrutura responsável 
por proteger o cérebro de compostos tóxicos, mas também permite a passagem de nutrientes 
e várias moléculas importantes para o parênquima cerebral. A função de barreira é 
determinada pelas células endoteliais, que em conjunto com os pericitos, astrócitos, lâmina 
basal, microglia e neurónios formam a unidade neurovascular. 
Entre as diferentes regiões cerebrais, bem como entre o parênquima cerebral e a corrente 
sanguínea, ocorre constantemente um grande fluxo de água e perturbações na homeostasia 
da água podem ter efeitos prejudiciais na função cerebral. As aquaporinas (AQPs) são canais 
de água responsáveis pelo transporte de água através da BHE, sendo a AQP4 uma das mais 
importantes no Sistema Nervoso Central (SNC). A AQP4 é expressa nas extremidades dos 
astrócitos que estão em contacto com os vasos sanguíneos. Além disso, alterações na AQP4 
podem levar à formação de edema cerebral devido a um aumento anormal do conteúdo de 
água no cérebro e um consequente inchaço cerebral. De facto, o edema cerebral tem sido 
observado em várias neuropatologias, incluindo em condições de consumo de MET. 
Assim, o objetivo do presente trabalho foi avaliar se a MET induz alterações na expressão da 
AQP4 e qual o papel dos astrócitos na toxicidade induzida por MET em células endoteliais. 
Os nossos resultados mostram que a MET leva a um aumento da expressão de AQP4 em 
culturas primárias de astrócitos, sem interferir com os níveis da proteína glial fibrilar acídica 
(GFAP - Glial Fibrillary Acidic Protein). Além disso, também testámos o efeito desta droga num 
modelo animal de intoxicação por MET (binge). Com este protocolo mostrámos que a MET 
induz um aumento da expressão da AQP4 no hipocampo e uma diminuição no córtex pré-
frontal, mostrando que as diferentes regiões apresentam diferente suscetibilidade para a MET. 
No entanto, quando avaliámos o conteúdo de água no cérebro total não observámos 
alterações significativas. 
Tendo em consideração o papel dos astrócitos na função da BHE, usámos para os estudos 
seguintes uma linha celular de células endoteliais de murganho (bEnd.3). Foi possível concluir 
que os meios condicionados de astrócitos (MCA) protegeram as células endoteliais (CEs) da 
morte celular induzida por MET (3 mM). No entanto, quando expusemos as CEs aos MCA 
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recolhidos de células expostas a concentração não tóxicas de MET (1 μM e 50 μM), 
observámos uma diminuição da expressão das proteínas das junções oclusivas (JOs), ocludina 
e claudina-5, mas não se verificou nenhum efeito na condição MCA controlo. 
Em suma, os nossos resultados mostram que a MET causa alterações na expressão da AQP4 
quer em culturas primárias de astrócitos quer no hipocampo de murganhos. Além disso, os 
astrócitos numa situação controlo parecem proteger as células endoteliais da morte celular 
induzida por MET, mas quando previamente expostos a MET os astrócitos provavelmente 
libertam fatores que interferem negativamente com a expressão de proteínas da JOs o que em 
última análise pode aumentar a permeabilidade da barreira. 
 
 
Palavras-chave: metanfetamina, barreira hemato-encefálica, astrócitos, aquaporina-4, células 
endoteliais 
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Abstract 
 
Methamphetamine (METH) is a potent and highly addictive psychostimulant which 
consumption in Europe has been increased over the last years. Several reports have 
demonstrated that oxidative stress, excitotoxicity, inflammation and mitochondrial 
dysfunction are some of the neurotoxic features of METH. More recently, it was shown that 
METH can also compromise the blood-brain barrier (BBB) function and cause cerebral edema. 
BBB is a structure responsible for protecting the brain from toxic compounds, but nevertheless 
allows the passage of nutrients and several important molecules into the brain parenchyma. 
The barrier function is determined by the endothelial cells, that together with pericytes, 
astrocytes, basal lamina, microglia and neurons form the neurovascular unit.  
Large water fluxes continuously take place between the different compartments of the brain, 
as well as between the brain parenchyma and the blood. Disturbances in this well-regulated 
water homeostasis may have deleterious effects on brain function. Aquaporins (AQPs) are 
water channels that contribute to water transport across BBB, being AQP4 one of the most 
important at the Central Nervous System (CNS). AQP4 is express on astrocytic end-feet in 
contact with brain vessels. Moreover, alterations in AQPs can originate cerebral edema due to 
abnormally increased water content and consequent brain swelling. Indeed, brain edema has 
been observed in several neuropathologies, including under conditions of METH consumption. 
Therefore, the aim of the present work was to investigate if METH induces alterations in the 
expression of AQP4 and the role of astrocytes against METH-induced toxicity of endothelial 
cells. 
Our results show that METH leads to an increase of AQP4 expression in primary cultures of 
astrocytes, without interfering with the glial fibrillary acidic protein (GFAP) levels. 
Furthermore, we also tested the effect of the drug in an animal model of METH intoxication 
(binge paradigm). With this protocol we showed that METH leads to an increase of AQP4 
expression in the hippocampus and to a decrease in the frontal cortex, demonstrating that 
different brain regions present different susceptibilities to METH. However, when the water 
content of whole brain was measured we did not observe significant alterations.  
Taking into consideration the role of astrocytes in the BBB function, we further used a mouse 
brain endothelial cell line (bEnd.3). It was possible to conclude that astrocyte-conditioned 
medium (ACM) was able to protect endothelial cells (ECs) against METH-induced cell death (3 
mM). However, when we exposed the ECs to ACM collected from cells exposed to non-toxic 
METH concentrations (1 μM and 50 μM), we observed that both ACM METH conditions caused 
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a decreased in the expression of the tight junction proteins (TJs), occludin and claudin-5, 
without any effect of the ACM control.  
Overall, our results show that METH causes an increase in AQP4 expression in both primary 
cultures of astrocytes and in mice hippocampus using an acute METH administration protocol. 
Moreover, astrocytes in a control situation seem to protect the endothelial cells from METH-
induced cell death, but when previously exposed to METH they probably release some factors 
that negatively interfere with the expression of TJs proteins that ultimately may increase 
barrier permeability.  
 
Keywords: methamphetamine, blood-brain barrier, astrocytes, aquaporin-4, endothelial cells 
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CHAPTER 1 
 
INTRODUCTION 
 
 
1.1. METHAMPHETAMINE 
1.1.1. METHAMPHETAMINE CONSUMPTION 
Methamphetamine (METH) is a psychostimulant compound that belongs to the amphetamine 
class of drugs, along with amphetamine and ecstasy (or 3,4-
methylenedioxymethamphetamine, MDMA), which has great similarity with the 
neurotransmitter dopamine (figure 1). METH can be consumed in various ways such as 
smoked, the most commonly, but can also be injected, snorted and taken orally (Winslow 
2007; Nakama 2008). Although METH is drug of abuse, it is also approved by the FDA to treat 
attention deficit hyperactivity disorder and extreme obesity (Kish, 2008). 
According to the last United Nations World Drug Report the worldwide amphetamines 
consumption is between 14 and 52.5 million among people aged 15-64, which represents 0.3% 
to 1.2% of annual prevalence, making METH the second most widely used drug globally 
(United Nations Office on Drugs and Crime, 2012). Concerning the consumption in Portugal, 
the last report is from “Instituto da Droga e da Toxicodepência, 2009” which showed that in 
2007, 0.9% of total population or 1.3% of young adult, was amphetamine consumer. However, 
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this report includes the group of amphetamines, excluding ecstasy, which means that there 
are no national statistics of detailed consumption of METH. 
Immediately after consumption, METH leads to euphoria, alertness, wakefulness, increased 
activity (Quinton et al., 2006; Kish et al., 2008), hyperthermia, and decrease in appetite 
(Yamamoto et al., 2010). Moreover, at long-term this drug originates anxiety, confusion, 
insomnias, mood disturbances, weight loss, among others (Buchanan et al., 2010). Indeed, 
chronic METH abusers can experience psychotic and violent behavior, impaired verbal learning 
and memory, visual and auditory hallucinations, delusions, and even seizures (Quinton et al., 
2006; Ramirez et al., 2009, Yamamoto et al., 2010; Buttner, 2011).  
 
 
Figure 1. The chemical structure of dopamine and methamphetamine clearly 
shows the similarity between both (adapted from Fleckenstein et al., 2007). 
 
1.1.2. THE EFFECTS OF METHAMPHETAMINE IN THE CNS:  
     A QUICK OVERVIEW 
At the cellular level, when this drug is present in the extracellular space it can enter into the 
cell by two ways: diffuse transport due to lipophilic characteristics of METH or via  membranar 
dopamine transporter. Due to its characteristics, METH can also enter the mitochondria or 
other cellular compartments. More specifically, it can be stored in vesicles containing 
dopamine by a mechanism similar to that above mentioned (Yamamoto et al., 2010). With the 
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increase of METH inside of these vesicles, there will be an increase of dopamine release from 
those vesicles into the cytoplasm (figure 2), which consequently causes oxidative stress 
accompanied by production of reactive oxygen species (ROS) and reactive nitrogen species 
(RNS). Moreover, the increase of dopamine in the cytoplasm can reverse the membrane 
transporters leading to a great release of dopamine into the synaptic cleft, which in the case of 
neurons can cause an overactivation of postsynaptic neurons (figure 2; Kish, 2008). 
 
 
Figure 2. Effect of METH on neuronal dopaminergic system. Methamphetamine 
is able to cross neuronal membranes, leading to a release of dopamine from 
storage vesicles, which consequently reverse the membrane transporter and 
dopamine is released to the synapse. A – control situation; B – after METH 
exposure (adapted from Kish, 2008). 
 
METH is also capable of inhibit the dopamine uptake (Rothman et al., 2001) leading to an 
increase in cytoplasmic and extracellular levels of dopamine, serotonin and norepinephrine, 
which can cause an increase in the production of ROS and RNS (Yamamoto et al., 2008; Kish, 
2008; Dietrich, 2009). This increase in oxidative stress has already been described either in 
human brain microvascular endothelial cells (Ramirez et al., 2009) and in vivo accompanied by 
an increased in lipid peroxidation in rat striatum (Yamamoto et al., 1998). Moreover, METH is 
able to inhibit glucose uptake in neurons and astrocytes (Muneer et al., 2011), as well as to 
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inhibit mitochondrial electron transport chain enzyme complexes, with consequent inhibition 
of mitochondrial function (Quinton et al., 2006; Yamamoto et al., 2010). 
Some cellular effects of METH can also be due to an interaction with the glutamatergic system. 
In fact, METH can lead to an increase of glutamate release (Mark et al., 2004), with a 
consequent increase in intracellular calcium levels and activation of several kinases and 
proteases resulting in the disruption of cytoskeleton and formation of ROS (figure 3; Cadet et 
al., 2007). These observations are supported by some previous works showing that 
pretreatment with glutamate receptor antagonists can prevent METH neurotoxicity (review in 
Yamamoto et al., 2008). It was also described by several authors that METH triggers a 
neuroinflammatory process (Yamamoto et al., 2008; Gonçalves et al., 2010) characterized by 
astrogliosis in the cortex, hippocampus and striatum (Pubill et al., 2003; Thomas et al., 2004; 
Sharma et al., 2009), as well as microglial activation in striatum and caudate-putamen (Pubill et 
al., 2003; Thomas et al., 2004; Bowyer et al., 2008). Similar results were observed in humans 
(Sekine, et al., 2008; Kitamura et al., 2010). Moreover, neuronal dysfunction or/and death, has 
already been demonstrated in mice and rats exposed to METH, and in several brain regions 
such as the hippocampus (Gonçalves et al., 2010) and caudate-putamen (Bowyer et al., 2008) 
in mice, and neocortex and limbic system in rats (Kuczenski et al., 2007). 
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Figure 3. Scheme summarizing the cytotoxicity mechanisms triggered by METH. 
After drug exposure there is an increase in neuronal glutamate release, as well as 
an increase in the levels of neuronal and glial reactive oxygen and nitrogen 
species (ROS and RNS, respectively), and cytokines, such as tumor necrosis factor 
α (TNF- α) and interleukins. The intracellular effects of a METH exposure include 
endoplasmic reticulum stress (ER stress) and mitochondrial stress. The ER stress is 
followed by release of calcium, activation of calpain and proteolysis of 
cytoskeleton proteins, such as tau and spectrin. The mitochondrial stress is 
characterized by the involvement of pro-apoptotic proteins, such as Bax and tBid, 
release of cytochrome C (Cyto c), and activation of caspases. At the nuclear level, 
METH can damage the DNA and increase the c-Jun and c-fos (Jun/fos) 
polymerization, which form the activator protein 1 transcription factor (AP-1). In 
turn, this can lead to the expression of several genes involved in differentiation, 
proliferation and apoptosis (adapted from Cadet and Krasnova, 2009). 
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1.2. BLOOD-BRAIN BARRIER: FUNCTION AND STRUCTURE 
 
Blood-brain barrier (BBB), which is one of the blood-neural barriers, is present in almost all 
brain regions, except in the brain ventricular system, also denominated circumventricular 
organs, which are responsible for the regulation of autonomic nervous system and endocrine 
glands (Ballabh et al., 2004; Cardoso et al., 2010). The BBB is formed by endothelial cells, 
pericytes, basal lamina, astrocytes, and also microglia and neurons (figure 4), which gives 
raised to the new concept of Neurovascular Unit. 
 
 
Figure 4. Neurovascular Unit. Endothelial cells and pericytes are surrounded by 
basal lamina. More recently, it has been described an important role for 
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astrocytes, microglia and neurons in BBB function (adapted from Abbott et al., 
2006) 
 
 
The BBB maintains the brain homeostasis and protects the brain against toxic compounds and 
blood fluctuations, but simultaneously provides nutrients essential for the normal brain 
function (Abbott et al., 2006; Kim et al., 2006; Dietrich, 2009; Cardoso et al., 2010). The 
transports across the BBB are limited and highly selective and generally we can divide into 
paracellular and transcellular routes (Figure 5).  The first is controlled by tight junctions 
between adjacent endothelial cells, whereas the second is mainly due to the presence of a 
complex transport system and selective receptors (Abbott et al., 2006; Cardoso et al., 2010). 
Water soluble agents go into the brain via tight-junctions, and ions, solutes and small lipophilic 
molecules cross BBB by diffuse transport according to the concentration gradient (Ballabh et 
al., 2004; Cardoso et al., 2010). The transporters are very important to allow the entrance of 
small and large hydrophilic molecules and nutrients into the brain, and also to eliminate 
cellular wastes. This system involves ATP consumption and is composed by a variety of 
carriers, such as glucose-transporter 1 (GLUT1), amino acids transporters (LAT1), ATP-biding 
cassettes (ABC) family of transporters, P-glycoprotein (Pgp) and multidrug resistance-related 
proteins (MRP) (Abbott et al., 2006; Kim et al., 2006; Cardoso et al., 2010). Regarding large 
hydrophilic molecules, like peptides and proteins, the transport is done by receptor-mediated 
endocytosis. Proteins, such as transferrin, insulin and leptin, have specific receptors, whereas, 
positively charged molecules like albumin and histone are transported by adsorptive-mediated 
endocytosis. However, under normal conditions, brain endothelial cells have less endocytic 
activity than non-cerebral endothelial cells (Ballabh et al., 2004; Abbott et al., 2006; Kim et al., 
2006). 
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Figure 5. Routes across blood-brain barrier.  The transporters of proteins and 
transcellular pathway are important to suppress the nutritional needs. The 
paracellular transport is relevant for ionic homeostasis. Transcytosis may also 
occur under physiological conditions, but at a low level (adapted from Abbott et 
al., 2006). 
 
 
1.2.1. COMPONENTS OF THE NEUROVASCULAR UNIT 
1.2.1.1. ENDOTHELIAL CELLS 
 
The brain endothelial cells (BECs) are the major cellular component of the BBB, and have 
unique characteristics that differentiate them from other endothelial cells, such as more active 
metabolism, more mitochondrial quantity and activity, presence of transporters, lower 
pinocytosis activity and also absence of fenestrations (Ballabh et al., 2004; Kim et al., 2006; 
Cardoso et al., 2010). These features provide to BECs the capacity to import and export 
different types of molecules, such as nutrients and toxic compounds, respectively, and also to 
provide energy to all transport systems (Cardoso et al., 2010). Between adjacent BECs there 
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are intercellular complexes - tight and adherens junctions - which seal the brain 
microvasculature forming the primary structure of BBB. 
 
1.2.1.2. PERICYTES 
Pericytes, also known as vascular smooth muscle cells, have contractile proteins which give 
them the capacity to regulate blood flow providing structural stability to brain 
microvasculature (Ballabh et al., 2004; Kim et al., 2006; Cardoso et al., 2010). These cells seem 
to be important to the maintenance of BBB basal lamina since they produce and release 
components of the basal lamina, such as proteoglycans (Cardoso et al., 2010). Communication 
of pericytes with BEC occurs via gap and tight junctions (Kim et al., 2006, Cardoso et al., 2010), 
and seems to be important for the maintenance of microvasculature and regulation of blood 
flow. 
 
1.2.1.3. BASAL LAMINA 
The basal lamina is the acellular component of BBB composed predominantly of collagen type 
IV, laminin, fibronectin and proteoglycans (Kim et al., 2006; Cardoso et al., 2010).  This 
structure is important for anchoring endothelial cells and pericytes, and for connecting these 
cells with other neighbour cells by cell adhesion molecules (Cardoso et al., 2010). 
 
1.2.1.4. ASTROCYTES 
Astrocytes, which are one type of glial cells, play an important role in the formation and 
maintenance of BBB (Ballabh et al., 2004; Abbott et al., 2006; Kim et al., 2006) and, indeed, 
one of their functions is to connect BECs with close neurons (Kim et al., 2006). Nevertheless, 
astrocytes can have a dual role. Regarding the protective effect, they release trophic and 
soluble factors important for neuronal survival and BBB formation and maintenance (Ballabh 
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et al., 2004), and are also responsible for the reuptake and metabolism of some 
neurotransmitters, more precisely glutamate and gamma-Aminobutyric acid (GABA) (figure 6) 
(Abbott et al., 2006; Allaman et al., 2011). Also, there are some studies clearly showing that 
astrocytes are important to neurogenesis and synaptogenesis (reviewed in Kim et al., 2006), 
and to the formation of tube-like structures (Ramsauer et al., 2002; Hawkins et al., 2005). 
Astrocytes are also involved in brain water homeostasis since they are the major cells that 
express water channels, denominated aquaporins, in the brain (Abbott et al., 2006; Nag et al., 
2009). 
 
 
Figure 6. Role of astrocytes in glutamate and GABA metabolism. These cells are 
responsible for the reuptake of glutamate and GABA, and then metabolize them 
to glutamine which is released back to neurons (adapted from Hyder et al., 2006). 
GABA: gamma-Aminobutyric acid 
 
On the other hand, astrocytes can release proinflammatory molecules, such as interleukin-
1beta (IL-1β) and tumour necrosis factor-alpha (TNF-α) (Abbott, 2002; Abbott et al., 2006) 
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(figure 7), as well as high concentrations of calcium to the extracellular space leading to 
excitotoxicity (Rossi et al., 2009). Additionally, astrocytes can also produce and release matrix 
metalloproteinases (MMPs), which are zinc-dependent endopeptidases capable of 
extracellular matrix degradation, such as basal lamina and tight junctions in the BBB 
(Rosenberg et al., 2002). 
 
 
Figure 7. Astrocytic and microglial response to damaged neuron. When there is 
an insult, astrocytes and microglia are recruited to the lesion area. The recruited 
astrocytes are able to release both trophic factors and inflammatory molecules 
(adapted from Monk et al., 2006). 
 
1.2.1.5. MICROGLIA 
Microglia is the major component of the brain immune system, and can present itself in three 
different phenotypes: surveying (resting) microglia, with small bodies; alerted microglia, with 
longer processes; and reactive microglia with phagocytic activity, (figure 8) (Hanisch and 
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Kettenmann, 2007). Importantly, resting microglia is responsible for the supervision of the 
brain microenvironment (Ransohoff et al., 2009). Activation of microglia can be triggered by 
several stimuli, such as inflammatory molecules release by astrocytes, increase in extracellular 
glutamate and blood serum molecules which can be a signal of BBB disruption (Ransohoff et 
al., 2009). Recently, these cells were found in the surroundings of BBB which suggest their 
participation in the barrier function (Choi et al., 2008). Microglia has been widely related with 
neuroinflammation, particularly due to their capacity to release inflammatory and cytotoxic 
molecules, such as TNF-α (Choi et al., 2008). 
 
 
Figure 8. Schematic representation of the microglia phenotypes. In healthy tissue 
the microglia remains its surveying (resting) state, but when a small damage 
happens in the brain tissue these cells became alert. In the last situation when the 
brain is exposed to strong or prolonged damage the microglial cells acquire its 
reactive phenotype (adapted from Hanisch and Kettenmann, 2007). 
 
1.2.1.6. NEURONS 
Neurons are considered the major and more important cells in the brain. Regarding BBB, 
neurons can regulate blood flow by local neuronal activation (Kim et al., 2006; Cardoso et al., 
2010) since BBB can be innervated by noradrenergic, serotonergic, cholinergic, and GABAergic 
neurons (Hawkins et al., 2005).  Although this important role of neurons, they are not directly 
connected to BECs, and required astrocytes to mediate this link (Kim et al., 2006). 
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1.2.2. INTERCELLULAR JUNCTIONS 
1.2.2.1. TIGHT JUNCTIONS 
 
Tight junctions (TJs) are formed by several proteins present between adjacent BECs that are 
responsible for the structure and organization of BBB. TJs act as physical barrier by limiting the 
paracellular transport, and also as membrane domain barrier, dividing apical and basal 
domains (Abbott et al., 2006; Kim et al., 2006; Cardoso et al., 2010). This polarity can be seen 
in transporter systems. 
The TJ proteins can be transmembranar, such as occludin, claudins and junctional adhesion 
molecules (JAMs), and cytoplasmic, like zonula occludens (ZO) and cingulin (figure 9). 
Moreover, transmembranar proteins can be divided into two groups: claudins/occludin, which 
have four transmembrane domains, and JAM, with one transmembrane domain (Cardoso et 
al., 2010). The cytoplasmic proteins are important to mediated interactions between 
transmembrane proteins and actin cytoskeleton (Mahajan et al., 2008). 
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Figure 9. Structure of tight and adherens junctions. The tight junctions (TJs) are 
formed by occludin and claudins, and by accessory proteins of zonula occludens 
family. Adherens junctions (AJs) are formed by cadherin and accessory proteins 
catenins. Accessory proteins of both tight and adherens junctions are able to 
connected the transmembrane proteins with actin cytoskeleton (adapted from 
Abbott et al., 2010) 
 
1.2.2.2. OCCLUDIN 
Occludin is a phosphoprotein with 65 kDa (Ballabh et al., 2004; Abbott et al., 2006) with four 
transmembrane domains and two extracellular loops. The first extracellular loop mediates 
Ca2+-independent adhesion, although ZO-1 presence is required (Cardoso et al., 2010). The 
cytoplasmic domain is responsible for the association between this protein and cytoskeleton, 
mediated by accessory proteins, like ZO-1 (Ballabh et al., 2004; Abbott et al., 2006). This 
protein is responsible for the high electrical resistance of the BECs contributing also for BBB 
stabilization. Nevertheless, recent data showed that occludin is not fundamental for TJ 
organization and function (Hawkins et al., 2005; Abbott et al., 2006; Persidsky et al., 2006; 
Cardoso et al., 2010). 
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1.2.2.3. CLAUDINS 
Claudins are a family of proteins with, at least so far, 24 members. Claudin-1 and -5 are the 
most important in brain microvascular TJs and these phosphoproteins with 20-22 kDa have 
four transmembrane domains (Ballabh et al., 2004; Cardoso et al., 2010). The domain 
responsible for the connection with actin cytoskeleton is the cytoplasmic and involves the ZO 
proteins (Ballabh et al., 2004). In fact, occludin and claudins show strong structural homology 
but with no amino acid sequence homology (Ballabh et al., 2004). The literature reports that 
claudins are the most important TJs protein, and forms the primary seal of TJs by 
homotypically connection with claudins in the adjacent BEC (Ballabh et al., 2004; Cardoso et 
al., 2010). Claudin-3 and -5 are associated with BBB integrity, contributing to lower 
permeability and also high transendothelial electrical resistance (Abbott et al., 2006; Mahajan 
et al., 2008; Cardoso et al., 2010). 
 
1.2.2.4. JUNCTIONAL ADHESION MOLECULES 
Junctional adhesion molecules (JAM-1, -2, and -3) have a molecular weight of 40 kDa, one 
transmembrane domain and one large extracellular domain with two loops (Hawkins et al., 
2005; Cardoso et al., 2010). These proteins belong to the immunoglobulin family and are 
important in cell-to-cell adhesion contributing to BBB maintenance and stabilization (Abbott et 
al., 2006). JAM-1 and -3 are expressed mainly in cerebral vessels (Ballabh et al., 2004; Cardoso 
et al., 2010) and do not need accessory proteins to bind with cytoskeleton but can be linked to 
ZO-1 protein (Mahajan et al., 2008). 
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1.2.2.5. CYTOPLASMIC PROTEINS 
This group of accessory proteins includes zonula occludens proteins (ZO-1, -2 and -3), cingulin, 
7H6 and others (Ballabh et al., 2004). ZO proteins are found in submembranous region and 
mediate the connection between claudin or occludin with actin cytoskeleton (Kim et al., 2006). 
These proteins belong to the membrane-associated guanylate kinase-like protein (MAGUK) 
family (Ballabh et al., 2004, Cardoso et al., 2010), and share between them several 
characteristics such as three PDZ domains, one SH3 domain and one guanyl kinase-like (GUK) 
domain (Ballabh et al., 2004). One of the PDZ domains, the PDZ1, is important to link claudin, 
whereas the GUK domain links occludin (Ballabh et al., 2004). 
ZO-1 is a 220 kDa phosphoprotein, and seems to be one of the most important ZO proteins 
(Kim et al., 2006; Cardoso et al., 2010), because its loss leads to an increase in permeability 
and decrease in tightness of the BBB (Choi et al., 2008; Cardoso et al., 2010). ZO-2 is a 160 kDa 
phosphoprotein that shows a great homology in amino acid sequence and structure with ZO-1 
(Ballabh et al., 2004; Cardoso et al., 2010). ZO-2 acts also as a transcription factor (Persidsky et 
al., 2006; Cardoso et al., 2010). Regarding ZO-3, it is a 130 kDa protein with homology to ZO-1 
and -2, and some studies have suggested that ZO-3 is capable to directly bind occludin and ZO-
1 (Cardoso et al., 2010). 
 
1.2.2.6. ADHERENS JUNCTIONS 
These proteins are present in the basal side of BEC, and so they regulate the paracellular 
transport and BECs adhesion (Hawkins and Davis, 2005). The adherens junctions (AJs) are 
formed by cadherin and catenin, the membrane and accessory protein, respectively (Perrière 
et al., 2007) (Figure 9). In fact, cadherin is a transmembranar glycoprotein responsible for Ca2+-
dependent cell-cell adhesion (Cardoso et al., 2010). This molecule establishes homophilic 
interactions with cadherins present in adjacent BECs (Ballabh et al., 2004). Catenin is an 
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accessory protein that mediates the connection between cytoplasmic domain of cadherins and 
actin cytoskeleton (Ballabh et al., 2004; Cardoso et al., 2010). However, catenins are not 
essential to AJ formation but for its stabilization (Cook et al., 2008), and there are four types of 
catenins: α-, β-, δ-, and γ-catenin (Cook et al., 2008; Cardoso et al., 2010). 
 
 
1.2.3. OTHER BARRIERS AT THE CNS 
 
In the CNS there are other barriers, such as the blood-cerebrospinal fluid barrier, arachnoid 
barrier, ventricular ependyma barrier, blood-retinal barrier and blood-spinal cord barrier 
(figures 10 and 11). Regarding brain barriers, the blood-cerebrospinal fluid barrier (BCFB; 
figure 10) is present in choroid plexus and it is important for the production and secretion of 
cerebrospinal fluid (CSF), which are related with protection of brain and spinal cord. The 
capillaries of this barrier are fenestrated and the barrier forming cells are the epithelial cells. In 
BCFB, TJs proteins like claudins, occludin and ZO-1 are also present but regarding claudins they 
differ from those in BBB because whereas claudins 1, 2 and 11 are present in BCFB, in the BBB 
there are claudins 1, 5 and 11 (Wolburg et al., 2001; Ballabh et al., 2004). The arachnoid 
barrier (AB; figure 10) is present in the meninges and is the least studied of all brain barriers. 
The barrier function of AB is formed by cells present in arachnoid membrane since the blood 
vessels are fenestrated. The AB function is to separate the subarachnoid space from the brain 
parenchyma (Saunders et al., 2008). The ventricular ependyma barrier (VEB; figure 10), also 
denominated fetal CSF-brain barrier, is a temporary barrier and only exist during the early 
developing brain being only permeable to small molecules like sucrose. In adult ependyma the 
VEB does not exhibit a restriction regarding passage of molecules between CSF and brain 
tissue (Saunders et al., 2008).  
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Figure 10. Schematic representation of barriers present in the brain. (a) The 
blood-brain barrier (BBB) separates the blood from de cerebral parenchyma, and 
is constituted by endothelial cells (endo), pericytes (peri), basal lamina (bm) that 
embrace endothelial cells and pericytes, and astrocytes (As endfoot) are also 
present and surround the brain microvessels. (b) The blood-cerebrospinal fluid 
barrier (blood-CSF barrier), with fenestrated capillaries, is located in the choroid 
plexus and is responsible for the production of cerebral spinal fluid. (c) The 
arachnoid barrier (AB) is present in the meninges and the blood vessels in 
arachnoid (Arach) and pial surface (PIA) has tight junctions similar to that found in 
BBB, however the vessels present in dura are fenestrated. (d, e) The ventricular 
ependyma barrier (VEB) differ in developing brain (d; fetal CSF-brain barrier) with 
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high tightness compared to adult ependyma (e) which allows a free passage 
between CSF and brain parenchyma (adapted from Saunders, et al., 2008). 
 
The blood-retinal barrier (BRB; figure 11) is important to deliver oxygen and nutrients to 
retina, and can be divided in two barriers: the inner and outer blood-retinal barrier. The outer 
BRB is formed by retinal epithelium with fenestrations, unlike the BBB, and the inner BRB by 
retina microvessels surrounded by pericytes and astrocytic end-feet (Choi et al., 2008). The 
blood-spinal cord barrier (BSCB; figure 11) is much similar to BBB, since it is also formed by 
microvessels surrounded by pericytes and astrocytes end-feet. The only differences between 
these two barriers are that BSCB has glycogen deposits and an increased permeability when 
compared to BBB (Choi et al., 2008). 
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Figure 11. The four blood-neural barriers found in the CNS. There are four 
different types of barriers. The blood-brain barrier (BBB) separates the blood from 
de cerebral parenchyma. The ependymal cells present in the blood-cerebrospinal 
fluid barrier are responsible for production of the cerebral spinal fluid. In this 
barrier the brain vessels are fenestrated which makes this barrier nonrestrictive 
however the epithelial cells have apical tight junctions conferring restrict 
intercellular molecule passage characteristic to the barrier. The blood-retinal 
barrier (BRB) segregates the retinal space from blood flow in two areas, the inner 
BRB, with a structure very similar to BBB, formed by microvessels surrounded by 
pericytes and astrocytes end-feet, and the outer BRB with fenestrated blood 
vessels and the retinal pigment epithelium layer forming the barrier. The blood-
spinal cord barrier protects the spinal cord microenvironment (adapted from Choi 
et al., 2008). 
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1.3. IMPACT OF METH ON BBB FUNCTION: WHAT IS KNOWN? 
 
Some groups have explored the effects of multiple or single doses of METH in BBB, and 
showed that this drug can cause BBB disruption through a decreased in TJ protein expression 
and/or structural rearrangement of these proteins (Mahajan et al., 2008; Ramirez et al., 2009; 
Martins et al., 2011). The BBB disruption induced by METH was described in several brain 
regions, such as cortex, hippocampus, thalamus, hypothalamus, cerebellum, amygdala and 
striatum (Bowyer et al., 2006; Ramirez et al., 2009; Sharma et al., 2009; Gonçalves et al., 
2010). Moreover, it has been extensively studied the effect of METH in astrocytes in both rats 
and mice exposed to acute or chronic METH administration (Pubill et al., 2003; Thomas et al., 
2004; Sharma et al., 2009; Gonçalves et al., 2010). This astrocyte activation can lead to 
neuroinflammation which potentiates the METH neurotoxicity, BBB dysfunction and can 
activate MMPs (Rosenberg, 2002; Gonçalves et al., 2010; Martins et al., 2011). 
Interestingly, Sharma and collaborators (2009) showed that simultaneously to BBB disruption 
induced by METH there was also water accumulation in the brain. Moreover, brain edema has 
been related with a dysfunction in astrocytic aquaporins (AQPs) (Nag et al., 2009, Sharma et 
al., 2009) and with the BBB breakdown. However, remains to be clarified if brain edema is a 
cause or a consequence of BBB disruption. Additionally, nothing is known about the effect of 
METH on AQPs, as well as the precise role of these water channels in BBB dysfunction induced 
by METH. 
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1.4. AQUAPORINS 
 
Aquaporins (AQPs) are water channels that can be divided in 13 different proteins (0 to 12; 
Itoh et al., 2005) as following: type 0, 1, 2, 4 and 5 are water permeable;  type 3, 7, 9 and 10 
are also known as aquaglyceroporins due to their permeability for water and other small 
nonpolar solutes like glycerol and urea; type 6 and 8 are also permeable to ions; and type 11 
and 12 have lack of structural characteristics related with the other aquaporins (Rojek et al., 
2008). The most expressed types in the brain tissue are type 1, 4 and 9 (Venero et al., 2001; 
Tait et al., 2008; Francesca et al., 2010). AQP1 has a role in CSF formation and is present in 
choroid plexus epithelium (Zelenina, 2010). AQP9  is important to energetic metabolism being 
present in neurons, in tanycytes in the wall of the third ventricle, and in endothelial cells of 
subpial blood vessels (Zelenina et al., 2005). The AQP4 has a role in both formation and 
resolution of cerebral edema, in K+ clearance during neuronal activity and can be found in 
astrocytes and ependymal cells (Zelenina et al., 2005). 
The AQPs are small proteins with approximately 30 kDa. Although permeability differences 
between the different types of aquaporins, all share a similar structure: the water channels 
forms a tetramer and each monomer has its own functional channel (Smith and Agre, 1991). 
Moreover, each monomer of AQP4 has six transmembrane domains with both terminals, 
carboxyl and amino, in the intracellular space (Preston et al., 1994; Nag et al., 2009) (figure 
12). 
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Figure 12. Schematic representation of aquaporin-4. Representation of the 3 
AQP4 isoforms, Mz, M1 and M23. The Mz isoform is the longer AQP4 isoform with 
364 amino acids. The M1 isoform has 323 amino acids and the M23 isoform is the 
shorter of the three isoforms with 301 amino acids. In this image is also possible 
to see residues that can be phosphorilated by different kinases, such as protein 
kinase C and calcium-calmodulin-dependent protein kinase II (adapted from 
Zelenina et al., 2010). 
 
AQP4 is expressed in astrocytes endfeet that surround the BECs (Amiry-Moghaddam and 
Ottersen, 2003). Indeed, AQP4 can be found in 3 different regions: in perivascular astrocyte 
endfeet where it plays an important role in BBB function (figure 13); in perisynaptic astrocyte 
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processes where it is involved in neurotransmitter uptake; and in astrocyte processes that are 
close to nodes of Ranvier and to nonmyelinated axons where AQP4 has a role in the clearance 
of K+ (review in Zelenina, 2010). In the brain, AQP4 is related with dystrophin glycoprotein 
complex, which include dystrophin, β-dystroglycan and syntrophin (Figure 14; Neeley et al., 
2001; Connors et al., 2004; Connors and Kofuji, 2006). In fact, Neely et al. (2001) showed that 
in mice lacking α-syntrophin the AQP4 became mislocalized and lose the characteristic 
distribution in astrocyte endfeet surrounding brain microvasculature. Furthermore, similar 
effect was observed in null mice for dystrophin (Vadja et al., 2002). 
 
 
Figure 13. Aquaporin-4 in astrocytes and water movement. This image shows 
water uptake and release by astrocytic endfeet. The arrows show the water 
movement (adapted from Amiry-Moghaddam et al., 2004). 
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AQP4 has two main isoforms (figure 12) originated by alternative splice, known as M1 and 
M23 (Jung et al., 1994). An additional isoform has been recently identified in rats as Mz and 
has a Nh2-terminal 41 amino acids longer than the isoform M1 that contain 323 amino acids 
(Moe et al., 2008). Isoform M23 is the smaller isoform of AQP4 with 301 amino acids but it is 
the most express isoform in the brain.  M23 is also characterized by its ability to form 
orthogonal arrays of particles (OAPs; Furman et al., 2003; Silberstein et al., 2004), which are 
supramolecular structures composed of aggregates of M23 and M1 isoforms (Sorlo et al., 
2008). However, in Chinese hamster ovary cells transfect with the two AQP4 isoforms, M1 and 
M23, the presence of M23 alone create large OAPs, whereas the presence of M1 alone creates 
almost exclusively singlets of AQP4 tetramers. Furthermore, when the two isoforms were 
expressed, the OAPs formed were more similar to the structures that can be found in 
astrocytes (Furman et al., 2003). It is already known that AQP4 has a crucial role in the control 
of water flux in and out the brain, and so on brain edema formation or resolution, respectively. 
Indeed, in several neuropathologies, such as trauma, ischemia, tumors of astrocytic origin, 
epilepsy and in neuromyelitis optica, it was demonstrated that the expression of AQP4 is 
altered (Tait et al., 2008; Nag et al., 2009; Zelenina, 2010). Nevertheless, many questions 
remain unanswered particularly related with the molecular mechanisms that regulate its 
function and its possible involvement on BBB dysfunction. 
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Figure 14. Anchoring of aquaporin-4 and interaction with dystrophin complex. 
Aquaporin-4 (AQP4) is anchored to cytoplasm and basal lamina through 
connection with α- and β-dystroglycan (α-DG and β-DG, respectively) and α-
syntrophin (α-syn). The association between AQP4 and α-syn occurs via PDZ 
domains. The α-syn links AQP4 to dystrophin-family proteins, such as dystrophin 
Dp-71 and α-dystrobrevin. Anchorage of AQP4 to basal lamina is mediated by α-
DG and β-DG that is associated with laminin and agrin (adapted from Amiry-
Moghaddam et al., 2004). 
 
There are two major types of brain edema: vasogenic and cytotoxic edema (figure 15). In 
vasogenic edema we have an accumulation of water in brain extracellular space, with AQP4 
having a role in the clearance of this water excess. In this type of edema, the entry of water is 
independent of AQPs and seems to be due to BBB opening. However, the exit of water from 
the brain is AQP-dependent (Venero et al., 2001; Tait et al., 2008; Nag et al., 2009; Francesca 
et al., 2010). The cytotoxic edema involves the swelling of astrocytes probably due to an 
increase of AQP4 activity (Tait et al., 2008; Nag et al., 2009; Francesca et al., 2010). Therefore, 
depending on the type of brain edema, different therapeutic strategies must be adopted. To 
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treat the vasogenic edema it is necessary to increase the AQP4 activity. However, regarding 
the cytotoxic edema the treatment necessarily involves the reduction of the activity of this 
water channel (Nag et al., 2009; Francesca et al., 2010). 
 
Figure 15. Cytotoxic and Vasogenic Edema. A) Cytotoxic edema, in which the 
increase in water brain content is due to an increase in astrocytic AQP activity. B) 
Scheme representing a vasogenic edema, where brain water accumulation is 
independent of AQP, but AQP4 has a key role in clearance of the excessive water 
volume (adapted from Tait, 2008). 
 
In an attempt to understand the role of AQP4 in cerebral edema, several studies with 
knockouts animals were preformed but the results were contradictory. Firstly, in models of 
cytotoxic brain edema, like hyponatremia (Papadopoulos and Verkman, 2007), bacterial 
meningitis (Manley et al., 2000) and in early focal cerebral ischemia (Papadopoulos and 
Verkman, 2005), the knockout animals showed a protection against this type of brain edema. 
On the other hand, regarding vasogenic edema the knockout animals showed a higher 
vulnerability to this type of brain edema associated with brain tumors (Papadopoulos et al., 
2004). These data demonstrated that in cytotoxic edema AQP4 is responsible for the increase 
in brain water content. However, in vasogenic edema AQP4 is responsible for removing the 
excess of water out the brain. 
Some studies have shown the involvement of AQP4 under epileptic conditions due to K+ 
clearance, and its deletion leads to an increased in seizure threshold and duration (Amiry-
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Moghaddam and Ottersen, 2003; Binder et al., 2006). Moreover, AQP4 is up-regulated in 
astrocyte-derived brain tumors and the level of this up-regulation can be associated with the 
tumor grade (Warth et al., 2007). 
Like other channels and membrane proteins, the regulation of AQPs is very important for 
normal function. Phosphorilation of two serine residues (Ser111 and Ser180) was 
demonstrated to be involved in the regulation of AQP4 activity (figure 12 and 16). The serine 
residue present in position 111 (Ser111) has been reported to be phosphorilated by 
calcium/calmodulin dependent protein kinase II (CaMKII), although this phosphorilation does 
not occur directly, but involving the activation of nitric oxide synthase (NOS) and cGMP-
dependent protein kinase (PKG; Gunnarson et al., 2008). Some studies suggested that 
phosphorilation of Ser111 leads to an increase in AQP4 water permeability (Gunnarson et al., 
2005; Gunnarson et al., 2008). Moreover, serine residue present in position 180 (Ser180) is 
phosphorilated by protein kinase C (PKC; Zelenina et al., 2002; McCoy et al., 2009) and this 
activation by PKC leads to a fast reduction in water permeability of AQP4, being prevented by a 
PKC inhibitor (Zelenina et al., 2002). On the other hand, in primary cultures of astrocytes there 
is no evidence of AQP4 phosphorilation by PKC, but the endogenous AQP4 is present in 
constitutively phosphorilated form (Nicchia et al., 2008; Kadohira et al., 2008). Kadohira and 
collaborators (2008) have also shown in primary cultures of astrocytes that phosphorilation of 
other COOH-terminal residues are involved in Golgi transition of AQP4. Moreover, 
phosphorilation of serine residue in position 276 has been correlated with internalization and 
degradation of AQP4 in renal epithelial cells (Madrid et al., 2001). 
Although the above mentioned evidence, aquaporins are also regulated by metals ions (figure 
16) like mercury (Hg) and lead (Pb). Most types of AQPs are inhibited by Hg (Amiry-
Moghaddam and Ottersen, 2003) except for AQP6 that is activated by this metal (Hazama et 
al., 2002). Concerning AQP4, first it was considered mercurial-insensitive (Nicchia et al., 2000; 
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Shi and Verkman, 1996), but a few years ago Yukutake and collaborators (2008) demonstrated 
that isoform M23 of AQP4 is inhibited by using Hg involving two cysteine residues in position 
178 and 253. The isoform M1 of AQP4 is probably regulated by mercury through NH2-terminal 
residues (review in Yukutake and Yasui, 2010). Other metal ions that are able to regulate AQP4 
are zinc (Zn) and copper (Cu) (figure 14), which cause an inhibition of isoform M23 of AQP4 
(Yukutake and Yasui, 2010). 
 
 
Figure 16. Structural 3D representation of aquaporin-4. Model of AQP4 structure 
showing the residues involved in AQP4 inhibition by phosphorilation and metal 
binding (adapted from Yukutake et al., 2010). 
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CHAPTER 2 
 
Material and Methods 
 
 
 
2.1. Animals and treatments 
Male wild-type C57BL/6J mice (3-month-old; 24–26 g body weight; Charles River Laboratories, 
Barcelona, Spain), were housed under controlled environmental conditions (12 h light:dark 
cycle, 24 ± 1ºC) with food and water ad libitum. All experimental procedures were performed 
according to the guidelines of the European Community for the use of animals in the 
laboratory (2010/63/EU) and the Portuguese law for the care and use of experimental animals 
(DL nº 129/92). 
Mice received four intraperitoneal (i.p.) injections, 2 h apart, of 10 mg/kg of METH (Chemistry 
Department, Faculty of Sciences, University of Porto, Portugal) or 100 μl of 0.9% NaCl (control 
group), and were sacrificed 24 h after the last injection.  
 
 
2.2. Primary cultures of mouse cortical astrocytes 
Astrocytes were isolated from C57BL/6J mouse pups aged P4-5. After decapitation, brain 
cortices were isolated and incubated with digestion solution [Hank’s Balanced Salt Solution 
(HBSS; GIBCO, Rockville, MD, USA), 0.25% Trypsin (SAFC, Kansas, USA), 0.001% DNase (SIGMA, 
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St Louis, MO, USA), 10 μl/ml Gentamicin (SIGMA)] for 20 min at 37ºC with gentle shaking each 
2 min.  Afterwards, the solution was centrifuged at 700 rpm for 2 min, the supernatant was 
discarded and the inhibitory digestion solution [HBSS with 10% fetal bovine serum (FBS)] was 
added and once more centrifuged at 700 rpm for 2 min. After discarded the supernatant, the 
pellet was resuspended in HBSS in order to dissociate the cells. Then, cell suspension was 
centrifuged at 1000 rpm for 5 min and the pellet resuspended with astrocyte medium (DMEM 
high glucose supplemented with 10% FBS and 1% gentamicin).  
Cells were plated in T-75 flasks at a density of 40000 cells/cm2. The medium was changed 6 h 
after culture and then every 2 days until reach confluence. Then, the flasks were shaking (200 
rpm for 4 h at 37ºC), the non-astrocytic cells were discarded (detached cells) and the 
astrocytes (adherent cells) were washed with dissociation medium [HBSS with 1mM 
ethylenediamine tetraacetic acid (EDTA, SIGMA)] followed by trypsinization with 0.1% Trypsin 
in HBSS. This process was stopped by incubation with astrocyte medium followed by 
centrifugation (1000 rpm for 5 min). The cells were resuspended, counted using Trypan blue 
dye, and plated at different densities depending on the experiments (Table 1). 
 
Table 1.  Astrocyte density according to the experiment 
EXPERIMENT 
CULTURE 
MULTIWELL PLATE 
FINAL CONCENTRATION 
(cells/ml) 
MEDIUM VOLUME 
(ml) 
Western 
blot/Astrocyte-
conditioned medium 
6 240 000 2 
Immunocytochemistry 12 with slides 60 000 1 
TUNEL assay 24 90 000 0.5 
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2.3. Astrocyte-conditioned medium (ACM) experiments 
Astrocytes were seeded in 6-well plates and after 3 days the medium was removed and the 
cells were washed with sterile PBS and incubated with two different METH concentrations (1 
and 50 μM METH) for 24 h. Afterwards, mediums were collected, centrifuged at 4000 rpm for 
10 min at 4ºC and then the supernatant was collected and stored at -80ºC until further use. 
 
 
2.4. bEnd.3 cell culture 
Mouse brain endothelial cells (bEnd.3) were purchased from American Type Culture Collection 
(ATCC; Manassas, VA, USA). Cells were cultured in Dulbecco’s Modified Eagle’s Medium 
(DMEM; GIBCO) supplemented with 10% FBS (GIBCO), 100 U/ml penicillin, and 10 μg/ml 
streptomycin (GIBCO) in non-coating flasks or multiwells, and maintained at 37ºC in a 
humidified 5% CO2/95% air atmosphere. Cells were allowed to reach confluence within 6-8 
days. After reaching confluence the cells were trypsinized with 0.25% trypsin (SAFC) in 0.53 
mM of EDTA (SIGMA) and then counted using Trypan blue and plated at different densities 
depending on the experiments (Table 2). Experiments were performed with cells from 
passages 24 to 33. 
 
Table 2. Cell densities used to plate the endothelial cells depending on the experiments 
EXPERIMENT CULTURE 
MULTIWELL PLATE 
FINAL CONCENTRATION 
(cells/ml) 
MEDIUM VOLUME 
(ml) 
Western blot 6 100 000 2 
TUNEL assay 24 10 000 0.5 
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2.5. Western blot analysis 
After appropriate treatment, mice were killed and hippocampi, striata and frontal cortex were 
dissected on ice. Regarding in vitro studies, endothelial cells and astrocytes were seeded in 6-
well plates and treated for 24 h with ACM (Control, 1 and 50 μM METH) or different METH 
concentrations (1 and 50 μM METH), respectively. Total protein of cells or mice brain regions 
was obtain by lysing the cells/tissue using Radio-Immunoprecipitation Assay lysis buffer (RIPA; 
0.150 M NaCl, 0.050 M Tris-base, ethylene glycol tetraacetic acid (EGTA), 0.5% sodium 
desoxicolate (DAC), 0.1% sodium dodecyl sulfate–polyacrylamide (SDS) and 1% X-Triton, pH 
7.5) supplemented with a protease inhibitor cocktail tablets (Roche) and 1 mM dithiothreitol 
(DTT) (Bioron, Porto, Portugal). Protein quantification was performed using the bicinchoninic 
acid (BCA) method (Pierce, Rockford, USA) with BSA as a standard, and stored at -20ºC until 
further use. Protein samples were prepared under reduced conditions by adding sample buffer 
(0.5 M Tris-HCl, 4% SDS, 30% glycerol, 10% SDS, 0.6 M DTT, bromophenol blue; pH 6.8) and 
heating at 95ºC for 5 min. Proteins (table 3) were separated by electrophoresis on 10% or 12% 
polyacrylamide gels at 160 V for 120 min and transferred to polyvinylidene fluoride (PVDF) 
membranes (Millipore, Madrid Spain) that were blocked with 5% (w/v) low fat milk in PBS-T 
(PBS containing 0.1% (v/v) Tween-20 (SIGMA)). Then, membranes were incubated overnight at 
4ºC with primary antibodies as described in Table 4. After washing, they were incubated with 
the respective alkaline phosphatase-conjugated secondary antibody (anti-mouse 1:10000 or 
anti-rabbit 1:20000) (Amersham GE Healthcare Life Science, USA) for 1 h at RT. The 
membranes were again washed with PBS-T, and proteins were visualized using the enhanced 
chemiofluorescence (ECF) reagent (Amersham) assay on the Typhoon FLA 9000 (GE Healthcare 
Bioscience AB, Uppsala, Sweden). Immunoblots were reprobed with glyceraldehyde 3-
phosphate dehydrogenase (GAPDH) antibody to ensure equal sample loading. Quantification 
of band density was performed using ImageQuant 5.0 software.  
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Table 3. List of proteins identified by western blot analysis 
PROTEIN MOLECULAR WEIGHT (kDa) AMOUNT OF PROTEIN (μg) 
Claudin-5 22 25 
Occludin 60-65 25 
Aquaporin-4 30 50 
GAPDH 37 - 
 
Table 4. List of primary and secondary antibodies used in western blot studies 
PRIMARY 
ANTIBODY 
DILUTION SOURCE SECONDARY 
ANTIBODY 
DILUTION SOURCE 
Mouse anti-
claudin-5 
1:100 Zymed 
laboratories, 
San Francisco, 
USA 
Anti-mouse IgG 
alkaline phosphatase 
conjugated 
1:10000 Amersham GE 
Healthcare 
Life Science  
Rabbit anti-
occludin 
1:250 Zymed 
laboratories  
 
Anti-rabbit IgG 
alkaline phosphatase 
conjugated 
1:20000 Amersham GE 
Healthcare 
Life Science  
Rabbit anti-
aquaporin-4 
1:1500 Chemicon, 
Millipore 
Anti-rabbit IgG 
alkaline phosphatase 
conjugated 
1:20000 Amersham GE 
Healthcare 
Life Science  
Mouse anti-
GAPDH 
1:1000 Abcam Anti-mouse IgG 
alkaline phosphatase 
conjugated 
1:10000 Amersham GE 
Healthcare 
Life Science  
 
2.6. Brain edema evaluation 
Brain water accumulation was evaluated by comparing the wet and dry weights, like previously 
described by Kenne et al. (2012). For that, mice were sacrificed and the intact brains were 
removed and weighed in order to obtain the wet weight (WW). Afterwards, the brains were 
dried for 72 h at 60ºC, and once again weighed to obtain the dry weight (DW). The percentage 
of brain water was calculated using the following formula:  [(WW – DW)/WW] x 100. As 
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positive control, mice were administered with 150 ml/kg (i.p.) of distilled water and sacrificed 
40 min after the injection (Haj-Yasein et al., 2011). 
 
 
2.7. TUNEL assay 
The terminal deoxynucleotidyl transferase dUTP nick-end labelling (TUNEL) assay permits the 
quantification of cell death by apoptosis since it will detect DNA fragmentation. This assay is 
characterized by the detection of specific activity of terminal transferase which attaches 
labelled biotin-16-2’-deoxy-uridine-5’-triphosphate to the 3’-OH end of DNA generated during 
apoptotic-induced DNA fragmentation. 
Astrocytes and endothelial cells were exposed to different concentrations of METH, and in 
another set of experiments, endothelial cells were exposed to different ACM for 24 h followed 
by TUNEL assay. Specifically, cells are fixed with 4% paraformaldehyde (PFA) and rinsed with 
phosphate-buffered saline (PBS; 137 mM NaCl, 2.7 mM KCl, 4.3 mM Na2HPO4, 1.47 mM 
KH2PO4, pH 7.4). Afterwards, cells were permeabilized with 0.25% Triton X-100 in PBS for 30 
min at RT and rinsed with PBS. Cells were then incubated with terminal deoxynucleotidyl 
transferase buffer (0.25 U/μl terminal transferase, 6 μM biotinylated dUTP, pH 7.5; Roche, 
Mannheim, Germany) for 1 h at 37ºC in a humidified chamber, and rinsed during 15 min with 
TB buffer (300 mM NaCl and 30 mM sodium citrate) followed by 5 min in PBS. The  incubation 
with Fluorescein (1:100; Vector Laboratories) was performed for 1 h at RT and the nuclei 
counterstaining with 4 μg/ml Hoechst 33342 (Sigma) for 5 min at RT. The slides were mounted 
in Dako Cytomation fluorescent medium (Dako North America, Carpinteria, USA) and stored in 
the dark. Fluorescent images were recorded using a camera Leica DMIRE2 incorporated on a 
Leica CTRMIC microscope (Leica, Germany). Six independent microscopy fields were acquired 
per coverslip with a magnification of x200. The number of apoptotic cells were expressed as 
percentages of total cells per field stained with Hoechst 33342 (Sigma).  
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2.8. Statistical analysis 
Statistical analysis was performed using GraphPad Prism 5.0 (GraphPad Software, San Diego, 
CA). Data was analyzed using the one-way ANOVA analysis of variance followed by Dunnett’s 
post hoc or Bonferroni’s post hoc to compare with control or among experimental conditions, 
respectively. In western blot studies for AQP4 expression in brain regions, statistical 
significance was determined using an unpaired one tailed Mann-Whitney test. Data were 
considered to be statistical different at values of P<0.05 and were presented as means ± SEM 
(standard error of the mean). For the quantification of TUNEL-positive cells, six independent 
microscopy fields per coverslip with 200× magnification were acquired and results are 
expressed as percentages of total cells stained with Hoechst 33342 per each field (n = number 
of fields). Every experimental condition was tested in three sets of independent experiments, 
unless stated otherwise, and performed in duplicates. 
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CHAPTER 3 
 
Results 
 
 
 
3.1. Effect of methamphetamine on astrocytes 
Astrocytes are one of the components of neurovascular unit (Kim et al., 2006) and have an 
important role in tightness and maintenance of the BBB function (Abbott et al., 2006). In the 
present study, we started by evaluating cell death induced by METH and it was possible to 
observe an increase in apoptotic cell death at a concentration of 500 μΜ and 1000 μΜ (Figure 
17; control: 4.03 ± 0.25%; 1 μM METH: 3.44 ± 0.41 %; 50 μM METH: 3.24 ± 0.49%; 250 μM 
METH: 3.85 ± 0.68%; 500 μM METH: 8.03 ±0.78%; 1000 μM METH: 8.25 ± 0.64%). For further 
studies in astrocyte cultures the two lower non-toxic concentrations (1 μM and 50 μM) were 
used. 
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Figure 17. METH-induced astrocytic cell death. Primary cultures of mouse cortical 
astrocytes were exposed to different METH concentrations (1-1000 µM) for 24 h 
and apoptotic cell death was evaluated by TUNEL assay. Data are expressed as 
mean % of total cells ± S.E.M., n = 36. ***P < 0.001, significantly different when 
compared to control using one way ANOVA followed by Dunnett’s Multiple 
comparison test.  
  
Afterwards, possible alterations in AQP4 expression, which is a water channel involved in 
water movement regulation (Zelenina et al., 2005), was analyzed in the absence and presence 
of different METH concentrations. As observed in figure 18 A, 50 μM METH leads to a 
significant increase in the protein levels of AQP4, with no significant effect at the 
concentration of 1 μM (control: 99.55 ± 1.72%; 1 μM METH: 120.80 ± 5.17%; 50 μM METH: 
176.60 ± 10.39%). Furthermore, to ensure that this increase in AQP4 expression is due to a real 
increase in the protein expression and not due to an increase in the number of astrocytes or 
astrocyte reactivation, we also evaluated GFAP expression. No differences were observed 
under various experimental conditions (Figure 18 B; control: 100.70 ± 7.89%; 1 μM METH: 
98.45 ± 4.84%; 50 μM METH: 100.90 ± 12.44%). 
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Figure 18. Effect of non-toxic METH concentrations on (A) AQP4 and (B) GFAP 
expression in astrocytes. (A) Primary cultures of mouse cortical astrocytes were 
exposed to METH (1 or 50 µM) during 24 h, and protein levels were evaluated by 
western blot. Above the bars, representative western blot images of AQP4 (32 
kDa), GFAP (50 kDa) and GAPDH (37 kDa) are shown. The results are expressed as 
mean % of control ± S.E.M., n=4-5, ***P < 0.001 significantly different when 
compared to control using one way ANOVA followed by Dunnett’s Multiple 
comparison test.  
 
 CHAPTER 3 – Results 
 
62 
 
 
3.2. Effect of methamphetamine on brain aquaporin 4 
expression and brain edema 
 
Recently, it was shown that acute METH treatment causes brain edema and this increase in 
brain water content is region-specific, with the hippocampus being more susceptible than the 
frontal cortex (Sharma and Kiyatkin, 2009; Kiyatkin and Sharma, 2011). Taking into 
consideration the crucial role of AQP4 water channels in the control of water flux in and out 
the brain, we further investigated the alteration of its expression in an animal model of METH 
intoxication (binge administration). It was possible to conclude that in the striatum METH did 
not induce significant alterations in AQP4 expression (115.50 ± 18.67%; n=3). However, in the 
hippocampus there was a significant increase in AQP4 expression (156.90 ± 9.56%; n=3). On 
the other hand, in frontal cortex METH led to a significant decreased in the AQP4 protein levels 
(58.42 ± 4.17%; n=3). 
 
Figure 19. Effect of acute METH administration on AQP4 expression in different 
brain regions. Mice were administered with METH (4x 10 mg/kg, 2h apart) and 
sacrificed 24 h post-injection. METH increased hippocampal AQP4 protein levels 
and there was a decrease in the frontal cortex, with no significant effect in the 
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striatum. Above the bars, representative western blot images of AQP4 (32 kDa) 
and GAPDH (37 kDa) are shown. The results are expressed as mean % of control ± 
S.E.M., n=3. *P < 0.05 significantly different when compared to control using 
Mann-Whitney post-test. 
 
We then hypothesize that the observed alterations in AQP4 expression in the different brain 
regions could be due astrocyte reactivation (Pubill et al., 2003; Sharma et al., 2009). Thus, 
GFAP expression was also evaluated, but no significant differences were observed in the three 
subregions analyzed (Figure 20; striatum: 109.50 ± 24.95%; hippocampus: 104.30 ± 26.12%; 
frontal cortex: 84.90 ± 19.83%). 
 
 
Figure 20. Effect of acute METH administration on GFAP expression in different 
brain regions. Mice were administered with METH (4x 10 mg/kg, 2h apart) and 
sacrificed 24 h post-injection. METH did not induce alterations in the GFAP protein 
levels in the different brain regions analyzed. Above the bars, representative 
western blot images of GFAP (50 kDa) and GAPDH (37 kDa) are shown. The results 
are expressed as mean % of control ± S.E.M., n=3. 
 
Afterwards, to confirm if METH also induced brain edema we evaluated the water content as 
previously described (Kenne et al., 2012). However, no alterations were observed in the brain 
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water content (control: 78.40 ± 0.09%; METH: 78.60 ± 0.26%; positive control: 80.44 ± 0.22%; 
figure 21). 
 
 
Figure 21. Quantification of brain water content. Mice were administered with 
METH or water and sacrificed 24 h post-injection. METH did not cause brain 
edema and the injection of distilled water induced a significant increase in brain 
water content (positive control). The results are expressed as mean % ± S.E.M., 
n=3, **P < 0.01 significantly different when compared to the control using one 
way ANOVA followed by Dunnett’s Multiple comparison test.  
  
 CHAPTER 3 – Results 
 
65 
 
 
3.3. Effect of astrocyte-conditioned medium on brain 
endothelial cells 
Our group has already demonstrated that METH causes disruption of the BBB and leads to a 
decreased in the expression of tight junctions proteins (Martins et al., 2011). Moreover, it has 
been speculated that astrocytes can also have a role in the protection of endothelial cells 
(Gesuete et al., 2011). So, we evaluated the possible effect of ACM in endothelial cell death, 
and only 3000 μM METH ACM increased cell death (control: 0.25 ± 0.02%; ACM control: 0.12 ± 
0.03%; 1 μM METH ACM: 0.09 ± 0.02%; 50 μM METH ACM: 0.14 ± 0.03%; 250 μM METH ACM: 
0.19 ± 0.05%; 500 μM METH ACM: 0.17 ± 0.03%; 1000 μM METH ACM: 0.29 ± 0.07%; 3000 μM 
METH ACM: 0.54 ± 0.17%). Importantly, the very low number of TUNEL positive cells even in 
the presence of 3000 µM METH ACM clearly shows the high resistance of these cells. 
 
 
Figure 22. Endothelial cell death induced by ACM. Only 3000 μM METH ACM (24 
h exposure) increased cell death and for all the other conditions ACM did not 
cause a significant alteration in the number of TUNEL positive cells. The results are 
expressed as mean % of total cells ± S.E.M., n=36, **P < 0.01 significantly different 
when  compared to the control using one way ANOVA followed by Dunnett’s 
Multiple comparison test.  
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In order to study the possible protection of endothelial cells by ACM, we exposed bEnd.3 cells 
to 3000 μM METH or to the same METH concentration but incubating the cells with CTR ACM 
medium instead of the normal ECs medium. As observed in figure 23, when we exposed 
endothelial cells to 3000 μM METH there was a significant increase of cell death. Interestingly, 
we concluded that ACM was able to protect endothelial cells from METH exposure (control: 
0.25 ± 0.02%; ACM control: 0.12 ± 0.03%; 3000 μM METH: 6.12 ± 0.44%; ACM control + 3000 
μM METH: 1.45 ± 0.12%).  
 
 
 
 
Figure 23. Endothelial cell death induced by METH and the protective role of 
ACM. The endothelial cells were exposed to 3000 μM METH during 24h or to the 
same concentration but in the presence of ACM instead of the normal endothelial 
cell medium. The results are expressed as mean % of total cells ± S.E.M. n = 36-40, 
***P < 0.001 significantly different when compared to the control (CTR) using one 
way ANOVA followed by Dunnett’s Multiple comparison test; §§§ P < 0.001 
significantly different when compared to 3000 μM METH, using Bonferroni’s 
Multiple comparison test. 
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Since METH can also lead to BBB opening, with decrease in tight junctions’ proteins expression 
(Ramirez et al., 2009; Martins et al., 2011), we also evaluated the effect of ACM on the 
expression of two tight junctions proteins, occludin and claudin-5. Regarding occludin, a very 
significant decrease in the expression levels can be observed in both ACM METH conditions (1 
μM and 50 μM METH ACM) (Figure 24 A; 1 μM METH ACM: 48.44 ± 4.91%; 50 μM METH ACM: 
37.17 ± 5.11%). Regarding the protein levels of claudin-5, there was also a significant decrease 
in its levels (Figure 24 B; 1 μM METH ACM: 56.84 ± 11.89%; 50 μM METH ACM: 57.57 ± 8.21%). 
 
 
 
Figure 24. Effect of ACM on the expression of tight junction proteins, (A) 
occludin and (B) claudin-5. Endothelial cells were exposed to ACM with two 
different METH concentrations (1 μM and 50 μM) for 24 h. Above the bars, 
representative western blot images of occludin (65 kDa), claudin-5 (24 kDa) and 
GAPDH (37 kDa) are shown. The results are expressed as mean % of control ± 
S.E.M., n=3-4, **P < 0.01, ***P < 0.001 and significantly different when compared 
to control using one way ANOVA followed by Dunnett’s Multiple comparison test; 
#P < 0.05,  ##P < 0.01 and ###P < 0.001 compared to control ACM using Bonferroni’s 
Multiple comparison test. 
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Discussion 
 
 
 
AQP4 is a water channel widely present in the brain, expressed mostly in astrocytes endfeet 
that surround brain microvessels (Tait et al., 2008; MacAulay and Zeuthen, 2010). These water 
channels have a role in controlling water homeostasis (Zelenina et al., 2005) and are involved 
in the formation (Manley et al., 2000; Papadopoulos and Verkman, 2007) and resolution 
(Papadopoulos et al., 2004) of brain edema. Moreover, it is already known that METH can 
cause brain edema in animals (Kiyatkin et al., 2007) and in humans (reviewed in Butner, 2011). 
So, we hypothesize if METH could have an effect in the expression of AQP4. To clarify this 
question we used primary cultures of astrocytes and started by evaluating the direct effect of 
several METH concentrations on cell death. We concluded that only concentrations equal and 
above 500 µM were toxic to astrocytes.  With these results we chose two non-toxic METH 
concentrations (1 and 50 μM METH) to evaluate the possible alterations in AQP4 expression 
levels. The results show that METH (50 µM) leads to an increase of AQP4 protein levels. 
Nevertheless, it was referred by our group and others that METH can cause astrogliosis in vivo 
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followed an acute METH administration (Sharma and Kiyatkin, 2009; Gonçalves et al., 2010), 
which could mask the real effect of METH on AQP4 expression. In order to clarify this issue, we 
analysed the levels of GFAP expression in primary cultures of astrocytes after METH treatment, 
but there were no alterations. This suggests that METH has a direct effect on AQP4 expression. 
Accordingly, Qi et al. (2011) used an ischemia in vitro model (oxygen and glucose deprivation, 
OGD, in primary cultures of rat astrocytes) and showed an increase in the expression levels of 
AQP4 at 4h after OGD, and this increase was inhibited by the antagonist of cysteinyl 
leukotriene receptor 2, which is an inflammatory mediator (Qi et al., 2011). Moreover, using 
an animal model of ischemia it was also observed an increase of AQP4 expression that was 
prevented by the administration of thrombin, which is a serine protease (Hirt et al., 2009). 
Regarding the possible link between AQP4 and BBB, Tomás-Camardiel et al. (2005) induced 
BBB disruption by in vivo administration of lipopolysaccharide (LPS) and observed an increase 
in both AQP4 mRNA and protein levels, and this effect was sustained up to 14 days after LPS 
administration (Tomás-Camardiel et al., 2005). Nevertheless, in our model the functional 
consequence of this increase remains to be investigated. 
It is known that METH causes brain edema with different susceptibilities among brain regions 
(Sharma and Kiyatkin, 2009). Thus, we also evaluated the levels of AQP4 in the striatum, 
hippocampus and frontal cortex using an acute protocol of METH administration. The binge 
treatment is currently the most frequently used model that mimics acute toxic dosing of METH 
(Krasnova and Cadet, 2009), and provides excellent relevance to intravenous and smoked 
routes of METH exposure in humans. In addition, it demonstrates the toxic effects of METH in 
non-tolerant users.  Interestingly, we observed different effects of METH in the three regions 
studied, with an increase of AQP4 expression in the hippocampus and a decrease in frontal 
cortex. We have also previously observed that METH-induced BBB permeability is dependent 
on the region, being the hippocampus the most affected brain region (Martins et al., 2011). As 
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for the in vitro studies, we showed that there was no astrogliosis which demonstrated that in 
the animal model there is also a direct effect on AQP4 expression. An increase in AQP4 levels 
has already been described in several pathological conditions, such as in inflammation induced 
by lysolecithin (Tourdias et al., 2011) and by LPS (Alexander et al., 2008), intracerebral 
hemorrhage stroke that also causes increase in BBB permeability (Tang et al., 2010), and 
traumatic brain injury with an increase in matrix metalloproteinase 9 expression and BBB 
permeability (Higashida et al., 2011). In all these studies the increase of AQP4 levels were 
always accompanied by an increase in the brain water content. Moreover, Yang and 
collaborators (2008) demonstrated that transgenic mice overexpressing AQP4 presented 
cytotoxic brain swelling. Interestingly, Jo et al. (2011) showed that AQP4 expression is reduced 
in piriform cortex with vasogenic edema induced by endothelin-1. Thus, since alterations in 
AQP4 can interfere with brain water content, we further evaluated if METH administration 
causes brain edema, but we did not observed any differences when compared to the control. 
One possible explanation for these results can be the fact that we measured the water content 
in total brain, whereas METH leads to alterations in AQP4 expression in a brain region specific 
manner. To clarify this question it would be important to evaluate edema formation in the 
hippocampus, frontal cortex and striatum, together with BBB permeability analysis. 
Considering that astrocytes are part of the neurovascular unit having a protective role in 
endothelial cells subject to some type of injury like ischemic (Gesuete et al., 2012), we also 
studied the effect of astrocyte-conditioned medium in cell death and in expression of tight 
junctions proteins. We have previously concluded that endothelial cells are quite resistant to 
METH because only at 3 mM it was possible to observe an increase of cell death (Almeida, C. 
2011, Master thesis). Some data shows that METH exposure in endothelial cells cultures leads 
to a decrease and also disorganization of tight junction proteins, such as occludin and claudin-5 
(Mahajan et al., 2008; Ramirez et al., 2009). Moreover, METH causes an impairment of glucose 
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transport system, with a decrease in the expression of glucose transporter 1 (GLUT-1) and 
inhibition of its activity (Muneer et al., 2011). Here, for the first time we showed that normal 
ACM has a protective role against METH-induced endothelial death, suggesting that astrocytes 
release some molecules that will somehow protect endothelial cells against the toxic effect of 
the drug. The protective effect has been already demonstrated in human endothelial cells 
(Siddharthan et al., 2007; Kuo et al., 2011). In these studies, the ACM decreased the 
permeability and increased transendothelial electric resistance, both used to assess the 
tightness of BBB. Moreover, Siddharthan et al. (2007) demonstrated that permeability 
decrease and increase of ZO-1 expression are more pronounced using ACM than astrocytes 
themselves. In future studies it will be important to analyse the composition of this medium in 
order to identify the protective factor(s). 
Astrocytes are very important in the formation and maintenance of BBB (Weiss et al., 2009), 
having also an important role in the formation of characteristic tube-like structure of BBB 
(Ramsauer et al., 2002). Additionally, astrocytes induce an upregulation of tight junction 
proteins, transporters and enzymes (reviewed by Abbott et al., 2006). Thus, we further 
evaluated the effect of ACM in the expression levels of two tight junctions proteins, claudin-5 
and occludin. Claudin-5 is very important to the normal BBB function since the knockout mice 
for claudin-5 show a disruption of the BBB (Wolburg et al., 2003; Argaw et al., 2009, Cardoso et 
al., 2010). Regarding occludin, it is a protein important for the BBB stabilization and regulatory 
properties but not essential for its barrier function because knockouts for this protein show no 
alterations in tight junctions formation, probably due to compensatory mechanisms (Hawkins 
and Davis, 2005; Cardoso et al., 2010). Moreover, our group recently showed that METH 
increases BBB permeability and decrease the protein levels of claudin-5, occludin and ZO-1 
(Martins et al., 2011). Here, we concluded that when astrocytes are exposed to non-toxic 
METH concentrations, they release some molecules that negatively affect the expression of 
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both TJ proteins. These results regarding ACM strengthens the idea that astrocytes have a dual 
role in the brain because they can be protective under conditions that trigger cell death, but 
on the other hand low concentrations of METH can lead to the release of molecules by 
astrocytes that have a negative impact on barrier functions.  Nevertheless, remains to 
understand if these changes are due to non-metabolized METH that is still present in ACM or 
to some factor(s) that astrocytes may release, or even due to the increase of AQP4 expression. 
In fact, some studies have suggested that AQP4 may regulate BBB. In hyperthensive rats it was 
shown that the increase of AQP4 expression was related with the beginning of hypertension 
(Ishida et al., 2006). On the other hand, AQP4 knockout mice do not show alterations neither 
in BBB permeability, TJ proteins, structure of brain microvessels, nor in brain water content 
(Saadoun et al., 2009; Tait et al., 2010, Haj-Yasein et al., 2011; Eilert-Olsen et al., 2012). 
However, in pathological situations, the lack of AQP4 leads to severe alterations in brain 
parenchyma, such as decrease in the expression of glutamate transporter 1 (GLUT1) that 
interferes with the glutamatergic system (Li et al., 2012), an increase in basal levels of 
apoptosis, and inhibition of proliferation and neuronal differentiation (Kong et al., 2008). 
Moreover, regarding the brain edema the lack of AQP4 leads to an increase in brain water 
content after a subarachnoid hemorrhage due to a disability of removing the excess of water 
content (Tait et al., 2010). In fact, these observations may explain why we have an increase in 
AQP4 expression without brain edema, since the system may up-regulate AQP4 expression in 
order to extrude excess water. However, other studies showed that the AQP4 overexpression 
aggravates the cytotoxic brain swelling after acute water intoxication demonstrating that in 
this situation the AQP4 is involved in edema formation (Yang et al., 2008). So, depending on 
brain edema, AQP4 can have opposite effects. Nevertheless, it is well known that AQP4 is an 
important protein for the normal function of the brain and BBB, but more studies are 
 CHAPTER 4 – Discussion 
 
76 
 
 
necessary to understand the mechanisms of AQP4 function in normal and pathological 
situations. 
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Conclusions 
 
 
 
 
With this work we showed for the first time that METH interferes with the levels of AQP4. 
Specifically, METH increased AQP4 expression in both primary cultures of astrocytes and in 
mouse hippocampus. However, we did not identify brain edema formation. Moreover, we 
have shown that in a control situation astrocytes release some factors that will protect the 
endothelial cells from METH toxicity and without any effect on the expression levels of claudin-
5 and occludin. However, if astrocytes are directly exposed to non-toxic concentrations of 
METH (1 μM or 50 μM), they will probably release factor(s) that lead to a downregulation of 
these two tight junction proteins, suggesting that under such conditions astrocytes may 
negatively interfere with BBB properties. 
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